Latest filings (excl ownership)
10-K/A
2023 FY
Annual report (amended)
29 Apr 24
10-K
2023 FY
Annual report
28 Mar 24
8-K
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2023 Financial Results and Business Highlights
28 Mar 24
8-K
Departure of Directors or Certain Officers
14 Feb 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
8-K
Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2023
9 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
8-K
Arcadia Biosciences (RKDA) Announces Second-Quarter and First-Half 2023 Financial Results and Business Highlights
10 Aug 23
8-K
Arcadia Biosciences (RKDA) Announces Strategic Review
20 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
12 Jun 23
S-8
Registration of securities for employees
25 May 23
10-Q
2023 Q1
Quarterly report
15 May 23
8-K
Arcadia Biosciences (RKDA) Announces First Quarter 2023
11 May 23
DEFA14A
Additional proxy soliciting materials
25 Apr 23
DEF 14A
Definitive proxy
25 Apr 23
EFFECT
Notice of effectiveness
18 Apr 23
424B3
Prospectus supplement
17 Apr 23
10-K/A
2022 FY
Annual report (amended)
13 Apr 23
CORRESP
Correspondence with SEC
13 Apr 23
UPLOAD
Letter from SEC
10 Apr 23
S-3
Shelf registration
3 Apr 23
CORRESP
Correspondence with SEC
3 Apr 23
10-K
2022 FY
Annual report
30 Mar 23
8-K
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2022 Financial Results and Business Highlights
30 Mar 23
424B3
Prospectus supplement
3 Mar 23
424B3
Prospectus supplement
3 Mar 23
424B3
Prospectus supplement
3 Mar 23
424B3
Prospectus supplement
3 Mar 23
424B3
Prospectus supplement
3 Mar 23
8-K
Entry into a Material Definitive Agreement
3 Mar 23
8-K
Material Modifications to Rights of Security Holders
28 Feb 23
8-K
Submission of Matters to a Vote of Security Holders
22 Feb 23
DEF 14A
Definitive proxy
6 Jan 23
8-K/A
Departure of Directors or Certain Officers
5 Jan 23
PRE 14A
Preliminary proxy
23 Dec 22
8-K
Material Modifications to Rights of Security Holders
8 Dec 22
8-A12G
Registration of securities
8 Dec 22
8-K
Arcadia Biosciences (RKDA) Announces CFO Transition
30 Nov 22
10-Q
2022 Q3
Quarterly report
10 Nov 22
8-K
Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2022
10 Nov 22
Latest ownership filings
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 24
4
Thomas J. Schaefer
5 Feb 24
SC 13G
SABBY MANAGEMENT, LLC
3 Jan 24
4
Thomas J. Schaefer
7 Aug 23
4
Deborah D Carosella
16 Jun 23
4
Amy Yoder
16 Jun 23
4
Albert D. Bolles
16 Jun 23
4
GREGORY D WALLER
16 Jun 23
4
Lilian Shackelford Murray
16 Jun 23
4
Kevin Comcowich
16 Jun 23
4
Stanley Jacot Jr
30 May 23
4
LAURA PITLIK
28 Apr 23
4
Stanley Jacot Jr
28 Apr 23
4
Thomas J. Schaefer
28 Apr 23
SC 13G
ARMISTICE CAPITAL, LLC
14 Feb 23
4
Thomas J. Schaefer
2 Feb 23
SC 13D/A
Moral Compass Corp
20 Jan 23
4
Thomas J. Schaefer
5 Jan 23
3
Thomas J. Schaefer
5 Jan 23
4
LAURA PITLIK
18 Aug 22
4
Pamela Haley
18 Aug 22
4
Pamela Haley
3 Aug 22
4
Kevin Comcowich
3 Jun 22
4
Albert D. Bolles
3 Jun 22
4
Lilian Shackelford Murray
3 Jun 22
4
GREGORY D WALLER
3 Jun 22
4
Amy Yoder
3 Jun 22
4
Deborah D Carosella
3 Jun 22
4
LAURA PITLIK
13 Apr 22
4
Pamela Haley
13 Apr 22
SC 13G/A
INTRACOASTAL CAPITAL, LLC
11 Feb 22
SC 13G/A
Hudson Bay Capital Management LP
4 Feb 22
4
Stanley Jacot Jr
4 Feb 22
3
Stanley Jacot Jr
4 Feb 22
4
LAURA PITLIK
13 Jul 21
3
LAURA PITLIK
13 Jul 21
4
Amy Yoder
4 Jun 21
4
Lilian Shackelford Murray
4 Jun 21
4
Deborah D Carosella
4 Jun 21
4
Kevin Comcowich
4 Jun 21